Literature DB >> 11334139

ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes.

T P Condon1, S Flournoy, G J Sawyer, B F Baker, T K Kishimoto, C F Bennett.   

Abstract

The release of tumor necrosis factor-alpha (TNF-alpha) from cellular membranes has been shown by different laboratories to be controlled by a disintegrin and metalloprotease, ADAM10 or ADAM17. In contrast, only ADAM17 has shown to be involved in L-selectin shedding. To determine the specific roles of ADAM10 and ADAM17 in the processing of TNF-alpha and L-selectin shedding, antisense oligonucleotides (ASO) targeting both ADAM10 and ADAM17 were identified. We show that ISIS 16337 reduces ADAM17 mRNA and ISIS 100750 reduces ADAM10 mRNA in a sequence-specific and dose-dependent manner in both Jurkat and THP-1 cells. The ADAM17 ASO (ISIS 16337) inhibited both TNF-alpha secretion in THP-1 cells and L-selectin shedding in Jurkat cells, whereas the ADAM10 ASO (ISIS 100750) did not significantly inhibit release of either protein. These results suggest that ADAM17 is one of the major metalloproteases involved in L-selectin shedding as well as TNF-alpha processing. The biologic substrates for ADAM10 in Jurkat and THP-1 cells remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334139     DOI: 10.1089/108729001750171353

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  27 in total

Review 1.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

Review 2.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

3.  ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding.

Authors:  Ying Li; Jennifer Brazzell; Amy Herrera; Bruce Walcheck
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

4.  Reactive oxygen species and p38 mitogen-activated protein kinase mediate tumor necrosis factor α-converting enzyme (TACE/ADAM-17) activation in primary human monocytes.

Authors:  Alasdair J Scott; Kieran P O'Dea; David O'Callaghan; Lynn Williams; Justina O Dokpesi; Louise Tatton; Jonathan M Handy; Philip J Hogg; Masao Takata
Journal:  J Biol Chem       Date:  2011-08-24       Impact factor: 5.157

5.  The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9.

Authors:  Maria Dolores Gutiérrez-López; Alvaro Gilsanz; María Yáñez-Mó; Susana Ovalle; Esther M Lafuente; Carmen Domínguez; Peter N Monk; Isidoro González-Alvaro; Francisco Sánchez-Madrid; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2011-03-02       Impact factor: 9.261

6.  ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils.

Authors:  Yue Wang; Jianming Wu; Robert Newton; Nooshin S Bahaie; Chunmei Long; Bruce Walcheck
Journal:  Biochim Biophys Acta       Date:  2012-12-08

7.  Glycosylation of a disintegrin and metalloprotease 17 affects its activity and inhibition.

Authors:  Anais Chavaroche; Mare Cudic; Marc Giulianotti; Richard A Houghten; Gregg B Fields; Dmitriy Minond
Journal:  Anal Biochem       Date:  2013-12-19       Impact factor: 3.365

8.  Demethylation of tumor necrosis factor-α converting enzyme promoter associated with high hepatitis B e antigen level in chronic hepatitis B.

Authors:  Zhen-Li Wang; Shuai Gao; Xin-You Li; Feng-Kai Sun; Feng Li; Yu-Chen Fan; Kai Wang
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

9.  Potential role for ADAM15 in pathological neovascularization in mice.

Authors:  Keisuke Horiuchi; Gisela Weskamp; Lawrence Lum; Hans-Peter Hammes; Hui Cai; Thomas A Brodie; Thomas Ludwig; Riccardo Chiusaroli; Roland Baron; Klaus T Preissner; Katia Manova; Carl P Blobel
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Regulation of mature ADAM17 by redox agents for L-selectin shedding.

Authors:  Yue Wang; Amy H Herrera; Ying Li; Kiran K Belani; Bruce Walcheck
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.